Health Care NervGen Pharma (TSXV:NGEN) closes US$15M private placement NervGen Pharma (NGEN) has closed a non-brokered private placement for gross proceeds of US$15,225,000The company issued... John Ballem1 min14 July 2022 09:30 (EDT)
Health Care The Market Online Deal Room NervGen Pharma (TSXV:NGEN) announces US$15M private placement NervGen Pharma (NGEN) has announced a non-brokered private placement for gross proceeds of US$15,225,000The company will... John Ballem1 min30 June 2022 09:15 (EDT)
Health Care NervGen Pharma (TSXV:NGEN) closes private placement NervGen Pharma (NGEN) has closed a non-brokered private placement for aggregate gross proceeds of $2,321,075The company... John Ballem2 mins29 November 2021 12:00 (EDT)
Health Care NervGen Pharma (TSXV:NGEN) closes private placement NervGen Pharma (NGEN) has closed a non-brokered private placement for gross proceeds of C$2,343,036NervGen sold 1,511,636... Trevor Abes1 min05 August 2021 15:00 (EDT)
Health Care NervGen Pharma (TSXV:NGEN) reviews 2021 financial gains and clinical phases NervGen Pharma Corp. (NGEN) reports strong financial and operational results for 2021An update on the Phase 1... Caroline Egan2 mins28 February 2022 15:30 (EDT)
Health Care NervGen Pharma (TSXV:NGEN) completes $9.2M bought deal financing NervGen Pharma (NGEN) has completed its public offering for gross proceeds of $9,200,000The underwriters, led by... John Ballem1 min12 November 2021 11:00 (EDT)
Health Care NervGen Pharma (TSXV:NGEN) announces pricing of overnight marketed equity offering NervGen will issue an aggregate of up to 3.25 million units at C$1.55 per unit for... John Ballem2 mins05 May 2021 13:45 (EDT)
Day Trading Market Summary Today’s market summary: commodities shine in volatile trading The TSX rose in early trading boosted by commodity stocks and upbeat domestic GDP data. The... Trevor Abes3 mins01 March 2022 16:30 (EDT)
